M. Brufani
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Cholinesterase and Neurodegenerative Diseases
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
- Pharmacology 15
- Cholinesterase and Neurodegenerative Diseases 7
- Microbial Natural Products and Biosynthesis 6
-
- Carbohydrate Chemistry and Synthesis 6
- Synthesis and Biological Evaluation 4
- Co-authors
- W. FedeliW. Keller‐SchierleinA. VaciagoS. CerriniLuciano CellaiHans ZähnerR. PELLICCIARIA. Ballio
- Journals
- Helvetica Chimica Acta (9 papers)Cellular and Molecular Life Sciences (5 papers)The Journal of Antibiotics (3 papers)Molecular Pharmacology (2 papers)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- ItalyGermanyUnited States
In The Last Decade
M. Brufani
43 papers receiving 686 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 331
- Toxicology 49
- Organic Chemistry 270
- Molecular Medicine 42
- Microbiology 6
Countries citing papers authored by M. Brufani
This map shows the geographic impact of M. Brufani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Brufani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Brufani more than expected).
Fields of papers citing papers by M. Brufani
This network shows the impact of papers produced by M. Brufani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Brufani. The network helps show where M. Brufani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Brufani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | New Acetylcholinesterase Inhibitors | 1997 | 8 |
| 2 | 1996 | 9 | |
| 3 | Synthesis of 2'-heptylcarbamoyloxy-2-methyl-6,7-benzomorphan: a new analogue of heptylphysostigmine (MF 201). | 1994 | 1 |
| 4 | New 1,2,4-oxadiazole derivatives: synthesis and adrenergic receptors binding studies. | 1992 | 2 |
| 5 | 1990 | 33 | |
| 6 | Structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives. | 1989 | 2 |
| 7 | 1988 | 33 | |
| 8 | 1985 | 2 | |
| 9 | A new simple method for determining the kinetic constants of inhibited acetylcholinesterase. | 1985 | 3 |
| 10 | 1982 | 13 | |
| 11 | Synthesis and pharmacological evaluation of new compounds with a potential action on the adrenergic system. | 1982 | 0 |
| 12 | 1974 | 48 | |
| 13 | 1972 | 31 | |
| 14 | 1972 | 37 | |
| 15 | 1971 | 8 | |
| 16 | 1968 | 24 | |
| 17 | 1968 | 38 | |
| 18 | 1966 | 18 | |
| 19 | 1964 | 39 | |
| 20 | [CRYSTALLINE AND MOLECULAR STRUCTURE OF THE RIFAMYCINS: PRELIMINARY DATA]. | 1963 | 2 |
About M. Brufani
M. Brufani is a scholar working on Pharmacology, Organic Chemistry, Molecular Medicine, Toxicology and Computational Theory and Mathematics, having authored 45 papers that have together received 748 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (7 papers), Microbial Natural Products and Biosynthesis (6 papers), Cancer therapeutics and mechanisms (6 papers), Carbohydrate Chemistry and Synthesis (6 papers), Computational Drug Discovery Methods (6 papers), Chemical Synthesis and Analysis (5 papers), Synthesis and Biological Evaluation (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Pharmacology (331 citations), Toxicology (49 citations), Organic Chemistry (270 citations), Molecular Medicine (42 citations) and Microbiology (6 citations). M. Brufani has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include W. Fedeli, W. Keller‐Schierlein, A. Vaciago, S. Cerrini, Luciano Cellai, Hans Zähner, R. PELLICCIARI, A. Ballio, C.G. Casinovi and M. Pomponi. Their work appears in journals such as Helvetica Chimica Acta, Cellular and Molecular Life Sciences, The Journal of Antibiotics, Molecular Pharmacology and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.